TRxADE HEALTH, INC. (“TRxADE”) (Nasdaq: MEDS) and Scienture, Inc. (“Scienture”) announce the closing of TRxADE’s business combination with Scienture in an all-stock transaction (the “Business Combination”). TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, in a combination of common stock and non-voting convertible preferred stock. The Business Combination results in a combined company that will be focused on bringing to market innovative branded, specialty pharmaceutical products that significantly enhance the standard of care, while adding value to patients, caregivers and the healthcare system.
Read the full article: TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103M //
Source: https://www.globenewswire.com/news-release/2024/07/26/2919535/0/en/TRxADE-Health-Inc-Announces-Business-Combination-with-Scienture-Inc-in-a-Transaction-Valued-at-103-Million.html